An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study

To evaluate the efficacy and safety of apatinib, an oral antiangiogenic drug, in patients with recurrent or refractory cervical cancer as salvage treatment, we retrospectively analyzed the medical records of recurrent or refractory cervical cancer patients admitted to the National Cancer Center/Canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Oncol
Main Authors: Li, Ning, Wang, Ziyi, Yuan, Guangwen, Sun, Yangchun, Zhang, Rong, Li, Xiaoguang, Li, Nan, Wang, Jing, Wu, Lingying
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327550/
https://ncbi.nlm.nih.gov/pubmed/32655637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3852373
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados